UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

ContraFect Corporation

---

(Name of Issuer)

 

Common Stock

---

(Title of Class of Securities)

 

212326102

---

(CUSIP Number)

 

June 12, 2015

---

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

---

  * Includes 591,016 shares of common stock that may be acquired upon the exercise of warrants.

** Calculated based on a total of 25,639,876 shares of common stock outstanding, which is comprised of (i) 20,320,728 shares of common stock outstanding as of May 11, 2015, as reported by the Company in its Quarterly Report on Form 10-Q filed with the

 

---

Securities Exchange Commission (the “SEC”) on May 14, 2015 (the “Quarterly Report”), (ii) 591,016 shares of common stock issuable upon the exercise of warrants, as described above, and (iii) 4,728,132 shares of common stock issued to Oracle Partners, L.P., Oracle Institutional Partners, L.P., among others, in a recent private placement, as described by the Company in the Current Report on Form 8-K filed with the SEC on June 12, 2015 (the “Current Report”).

---

  

---

 * Includes 472,813 shares of common stock that may be acquired upon the exercise of warrants.

** Calculated based on a total of 25,521,673 shares of common stock outstanding, which is comprised of (i) 20,320,728 shares of common stock outstanding as of May 11, 2015, as reported by the Company in its Quarterly Report, (ii) 472,813 shares of common stock issuable upon the exercise of warrants, as described above, and (iii) 4,728,132 shares of common stock issued to Oracle Partners, L.P., Oracle Institutional Partners, L.P., among others, in a recent private placement, as described by the Company in the Current Report.

 

---

    * Includes 118,203 shares of common stock that may be acquired upon the exercise of warrants.

 

---

** Calculated based on a total of 25,167,063 shares of common stock outstanding, which is comprised of (i) 20,320,728 shares of common stock outstanding as of May 11, 2015, as reported by the Company in its Quarterly Report, (ii) 118,203 shares of common stock issuable upon the exercise of warrants, as described above, and (iii) 4,728,132 shares of common stock issued to Oracle Partners, L.P., Oracle Institutional Partners, L.P., among others, in a recent private placement, as described by the Company in the Current Report.

---

 

   * Includes 591,016 shares of common stock that may be acquired upon the exercise of warrants.

 

---

** Calculated based on a total of 25,639,876 shares of common stock outstanding, which is comprised of (i) 20,320,728 shares of common stock outstanding as of May 11, 2015, as reported by the Company in its Quarterly Report, (ii) 591,016 shares of common stock issuable upon the exercise of warrants, as described above, and (iii) 4,728,132 shares of common stock issued to Oracle Partners, L.P., Oracle Institutional Partners, L.P., among others, in a recent private placement, as described by the Company in the Current Report.

---

Item 1(a). Name of Issuer:

 

ContraFect Corporation, a Delaware corporation (the “Issuer”).

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

 

28 Wells Avenue, 3rd Floor, Yonkers, New York 10701

 

Item 2(a). Name of Person(s) Filing:

 

This statement is filed by:

(i)

Oracle Partners, L.P., a Delaware limited partnership (“Partners”), with respect to shares of the Issuer’s common stock, par value $0.0001 per share (“Shares”), and warrants exercisable for Shares, directly owned by it;

(ii)

Oracle Institutional Partners, L.P., a Delaware limited partnership (“Institutional Partners” and, together with Partners, the “Oracle Partnerships”) with respect to Shares and warrants exercisable for Shares directly owned by it;

(iii)

Oracle Associates, LLC, a Delaware limited liability company (“Oracle Associates”), which serves as the general partner of the Oracle Partnerships, and may be deemed to indirectly own, by virtue of the foregoing relationships, the Shares and warrants exercisable for Shares directly owned by the Oracle Partnerships; and

(iv)

Mr. Larry N. Feinberg (“Mr. Feinberg”), who serves as the managing member of Oracle Associates, and may be deemed to indirectly own, by virtue of the foregoing relationship, the Shares directly owned by the Oracle Partnerships.

The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

 

Item 2(b). Address of Principal Business Office or, if none, Residence:

 

The address of the principal business office of the Reporting Persons is 200 Greenwich Avenue, 3rd Floor, Greenwich, Connecticut 06830.

 

Item 2(c). Citizenship:

 

Mr. Feinberg is a citizen of the United States of America.  Partners, Institutional Partners and Oracle Associates are organized under the laws of the State of Delaware.

 

Item 2(d). Title of Class of Securities:

 

Common Stock, par value $0.0001

 

Item 2(e). CUSIP Number:

 

212326102

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

 

 

---

 

Item 4. Ownership:

  

A. Larry Feinberg

(a) Amount beneficially owned: 1,773,048

(b) Percent of class: 6.92%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 1,773,048

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 1,773,048

 

B. Oracle Partners, L.P.

(a) Amount beneficially owned: 1,418,439

(b) Percent of class: 5.56%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 1,418,439

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 1,418,439

 

C. Oracle Institutional Partners, L.P.

(a) Amount beneficially owned: 354,609

(b) Percent of class: 1.41%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 354,609

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 354,609

 

D. Oracle Associates, LLC

(a) Amount beneficially owned: 1,773,048

(b) Percent of class: 6.92%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 1,773,048

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 1,773,048

---

Item 5. Ownership of Five Percent or Less of a Class:

 

If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person:

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group:

 

Not applicable.

 

Item 9. Notice of Dissolution of Group:

 

Not applicable.

 

Item 10. Certification:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

---

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated:  June 26, 2015

 

 

 

 

 

		/s/ Larry N. Feinberg                                                                                 Larry N. Feinberg, Individually
		ORACLE PARTNERS, L.P.
		By:  ORACLE ASSOCIATES, LLC, its general partner
		By:  /s/ Larry N. Feinberg                                                                                Larry N. Feinberg, Managing Member
		ORACLE INSTITUTIONAL PARTNERS, L.P.
		By:  ORACLE ASSOCIATES, LLC, its general partner
		By:  /s/ Larry N. Feinberg                                                                              Larry N. Feinberg, Managing Member
		ORACLE ASSOCIATES, LLC
		By:  /s/ Larry N. Feinberg                                                                              Larry N. Feinberg, Managing Member

---